- Received September 26, 2016
- Revision received March 20, 2017
- Accepted March 20, 2017
- Published first March 22, 2017.
Copyright & Usage
Copyright ©2017, American Association for Cancer Research.
- Dejan Juric1,
- Ian Krop2,
- Ramesh K. Ramanathan3,
- Timothy R Wilson4,
- Joseph A Ware5,
- Sandra Sanabria Bohorquez6,
- Heidi Savage4,
- Deepak Sampath7,
- Laurent Salphati8,
- Ray Lin5,
- Huan Jin9,
- Hema Parmar10,
- Jerry Y. Hsu9,
- Daniel D. Von Hoff11 and
- José Baselga12,*
- 1Massachusetts General Hospital
- 2Medical Oncology, Dana-Farber Cancer Institute
- 3Clinical Trials Program, Virginia G. Piper Cancer Center at Scottsdale Healthcare/TGen
- 4Oncology Biomarker Development, Genentech Inc.
- 5Clinical Pharmacology, Genentech Inc.
- 6Early Development, Genentech Inc.
- 7Translational Oncology, Genentech Inc.
- 8Drug Metabolism and Pharmacokinetics, Genentech Inc.
- 9Genentech Inc.
- 10Early Development Oncology, Genentech Inc.
- 11Translational Genomic Research Institute and Virginia G. Piper Cancer Center
- 12Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center
- ↵* Corresponding Author:
José Baselga, Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, BOX 20, New York, NY, 10065, United States. E-mail: